Show your support of CIRI with the 'CIRI Supporter' logo, available for display on your Web site upon joining CIRI.
Join today and help CIRI advance the cause of cleaner, more productive, and healthier indoor environments through scientific research!
How many cases of foodborne disease are there in the United States?
An estimated 76 million cases of foodborne disease occur each year in the United States. The great majority of these cases are mild and cause symptoms for only a day or two. Some cases are more serious, and CDC estimates that there are 325,000 hospitalizations and 5,000 deaths related to foodborne diseases each year. The most severe cases tend to occur in the very old, the very young, those who have an illness already that reduces their immune system function, and in healthy people exposed to a very high dose of an organism.
B. cepacia is the name for a group or “complex” of bacteria that can be found in soil and water. B. cepacia bacteria are often resistant to common antibiotics.
Populations susceptible to B. cepacia infection
B. cepacia poses little medical risk to healthy people. However, people who have certain health problems like weakened immune systems or chronic lung diseases, particularly cystic fibrosis (CF), may be more susceptible to infections with B. cepacia. B cepacia is a known cause of infections in hospitalized patients.
Symptoms of B. cepacia infection
The effects of B. cepacia on people vary widely, ranging from no symptoms at all, to serious respiratory infections, especially in patients with CF.
How B. cepacia infection is spread
Transmission of B. cepacia from contaminated medicines and devices has been reported.
In 2005, CDC was notified by several states of clusters of pneumonia and other infections caused by B. cepacia and associated with contaminated mouthwash. For more information see the CDC Health Advisory (HAN).
In 2004, CDC was notified of a voluntary recall of over-the-counter nasal spray due to contamination with B. cepacia complex.
For more information see the MMWR article and also the CDC Health Update (HAN) for a complete list of recalled lot numbers.
Also in 2004, B. cepacia was attributed to nosocomial infections among ICU patients and associated with exposure to sublingual probes. For more information see the MMWR article.
For a comprehensive list of medicines and devices that have been associated with B. cepacia contamination before 2003, see p. 43 of CDC’s Environmental Guidelines for Healthcare Facilities .
B. cepacia can also be spread to susceptible persons by:
Careful attention to infection control procedures like hand hygiene can help reduce the risk of transmission of this organism. For more information on hand hygiene and infection control practices see, Hand Hygiene in Healthcare Settings and Guideline for Isolation Precautions in Hospitals.
Treatment of B. cepacia infection
B. cepacia can be resistant to many common antibiotics. Decisions on the treatment of infections with B. cepacia should be made on a case-by-case basis.
The Cleaning Industry Research Institute (CIRI) is a 501.c.3 not-for-profit scientific, educational and research organization that applies science to the practice and improvement of cleaning and maintenance.
This abstract/brief is presented under the recognized "fair use" doctrine with respect to article copyright and intellectual property. Readers are encouraged to secure the full article from the originating publication source. Articles also may be obtained through a librarian, an information specialist or inter-library loan. In cases where payment is required under copyright it can be processed through a reference library or the Copyright Clearance Center at www.copyright.com.
CIRI provides no warranty, expressed or implied, and assumes no legal liability for the accuracy, completeness or usefulness of any information disclosed on its site. The views and opinions of authors expressed herein do not necessarily reflect those of CIRI principals, executives, science advisors or affiliates.